Physician profile
Silva Rodriguez
NPI 1285870139
$1,004.93
in general payments reported to CMS, 2019-2025
16 companies · $299 in 2025
The $299 reported for 2025 was more than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $69.59 · 2022: $51.39 · 2023: $131 · 2024: $454 · 2025: $299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $799 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $798.96 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $265.75 | 2024 | Veozah |
| Sumitomo Pharma America, INC. | $122.06 | 2025 | Gemtesa |
| Mayne Pharma Commercial LLC | $121.08 | 2025 | |
| Organon LLC | $71.00 | 2023-2025 | Nexplanon |
| Exeltis, USA INC. | $70.90 | 2024 | Slynd |
| Merck Sharp & Dohme LLC | $51.39 | 2022 | |
| Glaxosmithkline, LLC. | $47.83 | 2021-2023 | Trelegy Ellipta |
| Aspira Women'S Health INC | $47.16 | 2024 | Ova1 |
| Shield Therapeutics INC | $39.62 | 2023 | Accrufer |
| Pfizer INC. | $32.88 | 2021 | |
| Teleflex LLC | $30.45 | 2025 | Barrigel |
| Becton, Dickinson and Company | $28.58 | 2024 | Bd Max System, Bd Max Instrument |
| Abbvie INC. | $20.54 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.78 | 2023 | |
| Ambu INC. | $19.21 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $16.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Silva Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.